Determination of pantoprazole in human plasma by LC-MS-MS using lansoprazole as internal standard.

Autor: Peres O; Department of Pharmacology, State University of Campinas, Campinas, SP, Brazil., Oliveira CH, Barrientos-Astigarraga RE, Rezende VM, Mendes GD, de Nucci G
Jazyk: angličtina
Zdroj: Arzneimittel-Forschung [Arzneimittelforschung] 2004; Vol. 54 (6), pp. 314-9.
DOI: 10.1055/s-0031-1296977
Abstrakt: An analytical method based on liquid chromatography with positive ion electrospray ionization (ESI) coupled to tandem mass spectrometry detection was developed for the determination of pantoprazole (CAS 102625-70-7) in human plasma using lansoprazole (CAS 103577-45-3) as the internal standard. The analyte and internal standard were extracted from the plasma samples by liquid/liquid extraction using diethyl-ether/dichloromethane (70:30; v/v) and chromatographed on a C8 analytical column. The mobile phase consisted of acetonitrile/ water/methanol (57:25:18; v/v/v) + 10 mmol/l acetic acid + 20 mmol/l ammonium acetate. The method has a chromatographic total run time of 4.5 min and was linear within the range 5.0-5,000 ng/ mL. Detection was performed on a triple quadrupole tandem mass spectrometer by Multiple Reaction Monitoring (MRM). The intra- and inter-run precisions calculated from quality control (QC) samples were 4.2 % and 3.2 %, respectively. The accuracies as determined from QC samples were -5.0 % (intra-run) and 2.0 % (inter-run). The method herein described was employed in a bioequivalence study of two tablet formulations of pantoprazole.
Databáze: MEDLINE